Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer to Expand Newborn Screening Contract with Saudi Arabian Hospital

NEW YORK (GenomeWeb News) - PerkinElmer has struck a multi-year agreement to provide tools, materials, and expertise for newborn screening services to a hospital in Riyadh, Saudi Arabia.
 
Through the agreement, PerkinElmer will provide the King Faisal Specialist Hospital and Research Center with reagents, software, and screening know-how that the company said will double the hospital’s screening capacity by the end of 2008.
 
The company said the hospital hopes to increase its screening rate to as many as 200,000 newborns by the end of 2008 and as many as 400,000 by the end of 2009. The company’s regional distributor, HVD Vertriebs, will execute the contract, under which the hospital will use the company’s Specimen Gate screening lab information management system software.
 
The hospital currently uses PerkinElmer reagents to screen for congenital hypothyroidism, but this agreement will enable it to screen for three additional illnesses, including congenital adrenal hyperplasia, which affects adrenal glands; galactosemia, which can cause poor development or death; and biotinidase deficiency, which can cause seizures, developmental delay, and eczema and hearing loss.
 
Financial terms of the agreement were not released.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.